最新一本之道免费观看

水蜜蜜视频免费试看三分钟还不用下载的 手机播放中文字幕第一页 天天影院高清影视 天天看高清特色大片韩国 2018理论片完整一页 免费体验区试看3分钟午夜 污的漫画一般在哪看 谁有超级av网站 可以看裸的直播app 现代乡村刺激言情小说 偷情系列海岸线 天天影院官方下载 午夜剧场1 午夜大片试看20秒 春意影视院免费 色悠悠综合网 可以试看的app 日本成本人av动画无码 试看20分钟大片视频app 香蕉视频不限制版下载 偷拍自拍在绳线视屏 泰国电影晚娘2在线观看 我与妻子玩3真实经历 未成年人禁止观看 菠萝视频app 日本中文字幕无线观看2018 老施影院试看5分 午夜影2828院免费观看全片 小草莓直播537kc 先锋影音最新av资源网 日本最黄的电影视频 香蕉免费视频亚洲 蝴蝶飞app最新版的叫什么 茄子视频免费观看视频二维码 xo影院试看体10分钟 日本gif一级特黄 污到下面滴水的漫画清晰免费 香蕉视频宅男官方网址下载 岛国视频vip破解版 午夜神马超神第九影院达达兔 免费电影网站2018 网站大家懂我的意思吧香蕉 免费漫画网站大全韩国漫画app 日本激情看片 我尝一下可以吗 小说 天天天天天天看夜夜看 小草莓直播最新网址 日日漫画韩国漫画 先锋影音av资源网 成年进入视频 

  
  Home CAS Center for Excellence
  
  
  
 
Highlights/News
Seminars
Conferences
Media Reports
Jobs
Search
 
Address: 320 Yue Yang Road, Shanghai 200031, P.R. China
Tel: 86-21-54920000
Fax: 86-21-54921011
Email: sibcb@sibs.ac.cn
Website: www.sibcb.ac.cn
 
Targeting Cholesterol Metabolism in Macrophages to Eliminate Viral Infection
 
Viewed: 698
 

Recent evidence suggests a link between cholesterol metabolism and innate immunity. Upon viral infection, macrophages show reduced cholesterol synthesis accompanied by enhanced expression of antiviral genes, including type I interferon (IFN-I). 
 
IFN-I can induce 25-hydroxycholesterol (25-HC) accumulation, which blocks viral entry. However, it has been unclear whether other cholesterol-associated metabolic products or enzymes regulate innate immunity. 
 
A new study published in Immunity now provides important new information. WANG Hongyan’s team from the Center for Excellence in Molecular and Cellular Science, Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (CAS), in collaboration with Prof. WEI Bin at Shanghai University (the former PI of the Wuhan Institute of Virology of CAS), screened expression levels of multiple enzymes that regulate cholesterol metabolism to better understand how cholesterol metabolites combats infection. 
 
In order to find the enzymes or corresponding natural cholesterol metabolites involved in antiviral infection, the researchers screened differentially expressed genes in liver tissue from patients infected with hepatitis B virus and from mice infected with vesicular stomatitis virus (VSV).
 
DHCR7 (7-dehydrocholesterol reductase) is an enzyme that converts 7-dehydrocholesterol (7-DHC) into cholesterol. Patients carrying Dhcr7 mutations have mental retardation. However, the role of DHCR7 in innate immunity has been unclear. This study shows that DHCR7 knock-out (KO) or DHCR7 inhibitor treatment can promote IRF3 activation and type I interferon (IFNβ) production to clear multiple viruses in vitro or in vivo.  
 
Interestingly, Tamoxifen, a chemotherapy drug used to treat breast cancer, was approved by the U.S. Food and Drug Administration to inhibit DHCR7’s enzyme activity.
 
This study also reveals that Tamoxifen treatment inhibits infection by VSV and the Zika virus at the cellular level, suggesting a possible application for Tamoxifen as an anti-infective. Mice treated with the DHCR7 inhibitor AY9944 showed a significant increase in serum 7-DHC concentration, which promotes IRF3 phosphorylation and enhances IFNβ production in macrophages, thus protecting mice against lethal doses of VSV or the H1N1 influenza virus.
 
In addition, the research shows that viral infection enhanced AKT3 expression and 7-DHC treatment further activated AKT3. AKT3 directly bound and phosphorylated IRF3 at Ser385, together with TBK1-induced phosphorylation of IRF3 Ser386, to achieve IRF3 dimerization and full activation. 
 
In conclusion, this study reveals that both the intermediate cholesterol metabolite 7-DHC and DHCR7 inhibitors promote IFN-I production and an antiviral response by activating AKT3 and IRF3. These findings may aid in the development of new drugs to treat viral infections. The research also provides new insights on how cholesterol metabolism regulates innate immunity. 
 
This work was supported by grants from the Chinese Academy of Sciences, the Ministry of Science and Technology of China and the National Natural Science Foundation of China.
 
Reference: https://www.sciencedirect.com/science/article/pii/S1074761319304960?via%3Dihub

 

Copyright © 2017-2020 Shanghai Institute of Biochemistry and Cell Biology, CAS. All rights reserved